The Prognostic Role of Fusobacterium nucleatum in Head and Neck Cancers: A Meta-Analysis of Key Oncological Outcomes
By
Asuman Feda Bayrak
Mehmet Emin Arayici
Ozden Savas
Erdogan Ozgur
Aydan Ozkutuk
Enis Alpin Guneri
November 29, 2025
Clinical Scorecard: The Prognostic Role of Fusobacterium nucleatum in Head and Neck Cancers: A Meta-Analysis of Key Oncological Outcomes
At a Glance
Category Detail
Condition Head and Neck Squamous Cell Carcinoma (HNSCC) Key Mechanisms Influence of Fusobacterium nucleatum on tumor behavior and prognosis. Target Population Patients diagnosed with head and neck cancers, particularly HNSCC. Care Setting Oncology and surgical settings.
Key Highlights
Fusobacterium nucleatum is associated with both positive and negative prognostic outcomes in HNSCC. High levels of F. nucleatum may correlate with increased risk of cervical lymph node metastasis. HPV-positive HNSCC patients generally have better survival outcomes compared to HPV-negative patients. Guideline-Based Recommendations
Diagnosis
Consider the presence of Fusobacterium nucleatum in tumor specimens as a potential prognostic factor. Management
Further research is needed to clarify the role of F. nucleatum in treatment decisions for HNSCC. Monitoring & Follow-up
Monitor oncological outcomes such as overall survival and disease recurrence in relation to F. nucleatum presence. Risks
Assess the risk of metastasis in patients with high intratumoral F. nucleatum levels. Patient & Prescribing Data
Patients with head and neck cancers, particularly those with HNSCC.
The role of F. nucleatum in treatment response and outcomes remains to be fully elucidated.
Clinical Best Practices
Incorporate microbiome analysis in the evaluation of HNSCC prognosis. Utilize systematic reviews and meta-analyses to inform clinical decision-making. Related Resources & Content
